BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26566802)

  • 1. Mechanisms of action of BCL6 during germinal center B cell development.
    Huang C; Melnick A
    Sci China Life Sci; 2015 Dec; 58(12):1226-32. PubMed ID: 26566802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
    Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
    J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.
    Hatzi K; Melnick A
    Trends Mol Med; 2014 Jun; 20(6):343-52. PubMed ID: 24698494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
    Jardin F; Ruminy P; Bastard C; Tilly H
    Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
    Basso K; Dalla-Favera R
    Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.
    Saito M; Gao J; Basso K; Kitagawa Y; Smith PM; Bhagat G; Pernis A; Pasqualucci L; Dalla-Favera R
    Cancer Cell; 2007 Sep; 12(3):280-92. PubMed ID: 17785208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.
    Boccellato F; Anastasiadou E; Rosato P; Kempkes B; Frati L; Faggioni A; Trivedi P
    J Virol; 2007 Mar; 81(5):2274-82. PubMed ID: 17151114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells.
    Arguni E; Arima M; Tsuruoka N; Sakamoto A; Hatano M; Tokuhisa T
    Int Immunol; 2006 Jul; 18(7):1079-89. PubMed ID: 16702165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of BCL6 in normal and transformed germinal center B cells.
    Basso K; Dalla-Favera R
    Immunol Rev; 2012 May; 247(1):172-83. PubMed ID: 22500840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
    Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
    Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.
    Niu H; Cattoretti G; Dalla-Favera R
    J Exp Med; 2003 Jul; 198(2):211-21. PubMed ID: 12860928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.
    Cattoretti G; Pasqualucci L; Ballon G; Tam W; Nandula SV; Shen Q; Mo T; Murty VV; Dalla-Favera R
    Cancer Cell; 2005 May; 7(5):445-55. PubMed ID: 15894265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR; Gu W; Dalla-Favera R
    Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS.
    Qi CF; Jessberger R; Torrey TA; Taddesse-Heath L; Ohta Y; Morse HC
    Mol Immunol; 1999; 36(15-16):1043-53. PubMed ID: 10698307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p110δ phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression.
    Zhang TT; Makondo KJ; Marshall AJ
    J Immunol; 2012 Apr; 188(8):3700-8. PubMed ID: 22422878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.